CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors is a research paper published in Journal for ImmunoTherapy of Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P30CA046934
National Cancer Institute
Grant: R01CA258302
National Cancer Institute
Grant: R01CA269644
National Cancer Institute
Grant: R01CA279398
Dynamicure Biotechnology
Grant: none
National Institutes of Health
Grant: 1R01CA279398-01
The GPR171 pathway in cancer immunotherapy
National Institutes of Health
Grant: 5R01CA269644-03
Melanoma Immunotherapy with GPR182 blockade
National Institutes of Health
Grant: 3P30CA046934-20S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA258302-04
The CD93 pathway and melanoma therapy
FWCI
5.02
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals